Burning Mouth Syndrome Clinical Trial
Official title:
Patient Evaluation and Treatment of Oral Soft Tissue Diseases According to Generally Available, Standard Procedures and Therapeutic Modalities
This study offers evaluation and treatment of patients with diseases of the mouth or
systemic diseases that involve the mouth. The protocol is not designed to test new
treatments; rather, patients will receive current standard of care treatments. The purposes
of the study are: 1) to allow NIDCR's Gene Therapy and Therapeutics Branch staff to gain
more knowledge about oral soft tissue diseases and possibly identify new avenues of research
in this area; and 2) to establish a pool of patients who may be eligible for new studies as
they are developed. (Participants in this protocol will not be required to join a new study;
the decision will be voluntary.)
Patients of any age with oral diseases or systemic diseases involving the mouth may be
eligible for this study. Women of childbearing potential and women who are pregnant or
breastfeeding will only have tests and procedures and receive medications that pose no
greater than a minimal risk to the fetus.
Participants will have a comprehensive dental and medical examination, including a physical
examination of the head and neck. Additional tests and procedures that may be required for
diagnosis and to guide treatment include the following:
- Blood and urine tests - for routine laboratory studies, assessment of kidney and liver
function, and detection of viruses, fungi, bacteria or parasites
- Electrocardiogram - to record the electrical activity of the heart
- Biopsies - to examine tissue under the microscope. The method and number of biopsies
depends on the individual's specific condition and the tissue to be removed. For all
biopsies a local anesthetic (lidocaine with or without epinephrine) is injected at the
biopsy site. A punch biopsy uses a small sharp cookie-cutter instrument to remove a
small (about 1/10- to 1/5-inch) piece of skin. An excisional biopsy uses a small
surgical knife or scalpel to remove a piece of tissue, usually requiring some stitches
to close the wound.
- Diagnostic imaging - X-rays, photographs, or other tests as needed for diagnosis
Treatments include tablets, injections and topically applied medications. All preparations
are approved by the Food and Drug Administration and are commercially available. Patient
follow-up may vary from one visit to intermittent visits over a number of years, depending
on the patient's condition.
Status | Completed |
Enrollment | 999 |
Est. completion date | August 2002 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
INCLUSION CRITERIA Patients of any age, both genders, and all racial/ethnic groups with oral diseases or systemic diseases with oral manifestations that will help the branch fulfill the objectives listed in Section 1.0. Women of childbearing potential, or who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child. Only diagnosis without radiographs will be performed. EXCLUSION CRITERIA A written referral is needed from the patient's physician or dentist. No patients with significant cognitive impairment. No pregnancy or lactation, if this status precludes proposed diagnostic procedures or therapies because of unknown, untoward effects on mother and/or child. |
N/A
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Dental And Craniofacial Research (NIDCR) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Dental and Craniofacial Research (NIDCR) |
United States,
Axéll T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med. 1996 Feb;25(2):49-54. Review. — View Citation
Lozada-Nur F, Miranda C. Oral lichen planus: epidemiology, clinical characteristics, and associated diseases. Semin Cutan Med Surg. 1997 Dec;16(4):273-7. Review. — View Citation
Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Feb;81(2):141-7. Review. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04475614 -
Therapeutic Options for Treatment of Burning Mouth Syndrome
|
N/A | |
Completed |
NCT00374673 -
Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders
|
Phase 3 | |
Completed |
NCT02964728 -
Botulinum Toxin in Burning Mouth Syndrome
|
Phase 2 | |
Completed |
NCT04535973 -
Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
|
||
Recruiting |
NCT06040190 -
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
|
Phase 4 | |
Not yet recruiting |
NCT05059418 -
Burning Mouth Syndrome - New Diagnostic Criteria and Treatment
|
N/A | |
Recruiting |
NCT01867151 -
Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome
|
N/A | |
Completed |
NCT05872789 -
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
|
N/A | |
Completed |
NCT05871580 -
Effect to the Photobiomodulation in the Burning Mouth Syndrome
|
N/A | |
Recruiting |
NCT05309070 -
The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome
|
N/A | |
Completed |
NCT05399238 -
Thermography and Burning Mouth Syndrome
|
||
Completed |
NCT02580734 -
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
|
N/A | |
Completed |
NCT02382029 -
Acupuncture Versus Clonazepam in Burning Mouth Syndrome
|
Phase 0 | |
Recruiting |
NCT05819697 -
Reducing Patient Memory Recall in the Burning Mouth Patient Population
|
||
Completed |
NCT02757612 -
Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
|
N/A | |
Completed |
NCT00862576 -
A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
|
N/A | |
Not yet recruiting |
NCT04189367 -
Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine
|
Phase 3 | |
Completed |
NCT00001524 -
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
|
Phase 2 | |
Recruiting |
NCT04481841 -
Head Yuanshi Dian Therapy in Burning Mouth Syndrome
|
Early Phase 1 | |
Completed |
NCT02686359 -
Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)
|
N/A |